Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CL (ADMET) | > 320 microL/min/mg | Intrinsic clearance in human liver microsomes | ChEMBL. | 26258602 |
IC50 (binding) | = 4.5 | Inhibition of DGAT1 (unknown origin) assessed as effect on incorporation of [1-14C]decanoyl moiety into TG using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates | ChEMBL. | 26258602 |
IC50 (binding) | = 4.5 | Inhibition of MGAT2 (unknown origin) assessed as effect on incorporation of [1-14C]decanoyl moiety into DAG using [1-14C]decanoyl-CoA and 1-decanoyl-rac-glycerol as substrates | ChEMBL. | 26258602 |
IC50 (binding) | = 6.2 | Inhibition of MGAT3 (unknown origin) assessed effect on incorporation of [1-14C]decanoyl moiety into triacylglycerol using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates pre-incubated for 30 mins before substrate addition | ChEMBL. | 26258602 |
IC50 (binding) | = 682 nM | Inhibition of MGAT3 (unknown origin) assessed effect on incorporation of [1-14C]decanoyl moiety into triacylglycerol using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates pre-incubated for 30 mins before substrate addition | ChEMBL. | 26258602 |
IC50 (binding) | = 30 uM | Inhibition of MGAT2 (unknown origin) assessed as effect on incorporation of [1-14C]decanoyl moiety into DAG using [1-14C]decanoyl-CoA and 1-decanoyl-rac-glycerol as substrates | ChEMBL. | 26258602 |
IC50 (binding) | = 31 uM | Inhibition of DGAT1 (unknown origin) assessed as effect on incorporation of [1-14C]decanoyl moiety into TG using [1-14C]decanoyl-CoA and 1,2-didecanoyl-sn-glycerol as substrates | ChEMBL. | 26258602 |
IC50 (binding) | > 40 uM | Inhibition of DGAT2 (unknown origin) using [1-14C]decanoyl-CoA and didecanoyl-sn-glycerol substrates incubated for 40 mins | ChEMBL. | 26258602 |
IC50 (binding) | > 40 uM | Inhibition of MGAT1 (unknown origin) assessed as effect on incorporation of [1-14C]decanoyl moiety into DAG using [1-14C]decanoyl-CoA and 2-oleoylglycerol as substrates | ChEMBL. | 26258602 |
Inhibition (ADMET) | = 29 % | Inhibition of CYP2C8 (unknown origin) at 3 uM | ChEMBL. | 26258602 |
Inhibition (ADMET) | = 35 % | Inhibition of CYP2C9 (unknown origin) at 3 uM | ChEMBL. | 26258602 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.